Thomas Martin Krulle

This inventor holds 8 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Chdi Foundation, Inc., Prosidion Limited, Osi Pharmaceuticals, Inc.. Active years: 2008-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Martin Krulle. Retrieved from https://idiyas.com/inventor/thomas-martin-krulle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 8 (Patent Applications = 7)

% Patents Active = 37.5

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 8)

Average Co-Inventor Count = 9.3

ph-index = 3

Forward Citations = 23(Granted Patents)

Company Filing History:

3 out of 56

Chdi Foundation, Inc.

Osi Pharmaceuticals, Inc.

patents

4. 1 out of 834,708

Other

patents

Years Active: 2008-2022

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11344637 - Probes for imaging huntingtin protein (2022-05-31),

2. 10765764 - Probes for imaging huntingtin protein (2020-09-08),

3. 10137211 - Probes for imaging Huntingtin protein (2018-11-27),

4. 8278442 - Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders (2012-10-02),

5. 8158622 - Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase (2012-04-17),

6. 8063247 - Bicyclic aryl and heteroaryl receptor modulators (2011-11-22),

7. 7884112 - Pyrrolopyridine-2-carboxylic acid hydrazides (2011-02-08),

8. 7405210 - Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase (2008-07-29),

Title: The Innovative Mind of Thomas Martin Krulle

Introduction

Thomas Martin Krulle, a prominent inventor based in Oxford, GB, has made significant contributions to the field of imaging proteins, particularly in relation to the huntingtin protein. With a remarkable portfolio of 8 patents, Krulle continues to push the boundaries of scientific innovation.

Latest Patents

Among his latest inventions, Krulle has developed advanced probes for imaging the huntingtin protein. These imaging agents comprise a compound of Formula I, or a pharmaceutically acceptable salt thereof, along with methods for their use. This cutting-edge work highlights his dedication to enhancing imaging techniques in biomedical research.

Career Highlights

Krulle's professional journey includes valuable tenures at notable organizations such as CHDI Foundation, Inc. and Prosidion Limited. His experience at these companies has equipped him with the knowledge and resources to further develop his innovative ideas into fruitful inventions.

Collaborations

Throughout his career, Krulle has collaborated with distinguished colleagues, including Stuart Edward Bradley and Martin James Procter. These professional relationships have played a crucial role in fostering a collaborative environment that enhances the quality and reach of his inventions.

Conclusion

Thomas Martin Krulle remains a key figure in the field of protein imaging, with his patents serving as a testament to his innovative spirit and dedication to scientific advancement. As he continues to work on groundbreaking technologies, the impact of his contributions will undoubtedly resonate within the scientific community for years to come.

Profile summary based on public USPTO records.